Shades of Green, led by Daniel Pacurar of Boreal Orchards, is developing innovative approaches for sustainable and adaptive greening solutions both for urban environments and for restoring disturbed ecosystems. The aim is to create moss-coated solutions for outdoor and indoor spaces that are both functional and aesthetic.
We have developed a new class of orally highly active anti-cryptosporidium agents. The product would be the first efficient anti-cryptosporidium therapy on the animal health market.
There is a growing and heterogeneous group of patients who need dental surgery due to diseases or accidents. We have developed a green, mesoporous scaffold material with antimicrobial properties that has superior osteogenic properties compared to other commercial products.
We are developing safe and resistance-breaking molecules that target an enzyme essential for nerve signaling in mosquitoes via a new mode of action. In contrast to current insecticides, we have designed our molecules to specifically target mosquitoes, without affecting other organisms.
Triple-negative breast cancer, a hard-to-treat cancer subtype more common in young women, needs improved drugs to increase patient survival. Our innovation, a small molecule that targets G-quadruplex DNA structures, will selectively eradicate triple-negative breast cancer cells, and thereby improve treatment.
Fibrotic disorders are an increasing cause of morbidity and mortality worldwide contributing to approx. 45% of deaths in the developed world. A major cause of liver fibrosis is NASH, a severe form of the metabolic condition non-alcoholic fatty liver disease (NAFLD).
Food security can no longer rest on a bedrock of wasteful, fossil fuel-based fertilizer that create the environmental risk of leaching into aquatic ecosystems and causing eutrophication. Cropcision offers a step-change enhancement in fertilizer efficiency.
NanoBio Select@ is developing novel highly sensitive detection devices with aims to improve immunoassay technologies.
We are developing a new generation of photosensitizers to be used in photodynamic therapy (PDT) to treat more cancer types with minimum side-effects.
